Aurinia Pharmaceuticals Inc.
AUPH
$8.18
$0.080.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 107.37% | 70.78% | 30.78% | 35.34% | 27.88% |
| Total Depreciation and Amortization | 66.95% | 182.38% | 707.67% | 510.33% | 330.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.32% | 12.22% | 8.08% | -5.71% | 17.58% |
| Change in Net Operating Assets | 197.15% | -65.36% | -88.57% | -97.15% | 17.74% |
| Cash from Operations | 232.66% | 176.59% | 95.64% | 68.37% | 57.93% |
| Capital Expenditure | 60.86% | 45.93% | 72.21% | 33.75% | -145.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 760.37% | -103.12% | 54.48% | 1.31% | 90.08% |
| Cash from Investing | 685.48% | -79.35% | 54.84% | 2.45% | 88.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.59% | -345.20% | -- | -- | -- |
| Issuance of Common Stock | 29.22% | -0.52% | 58.84% | 51.70% | 194.86% |
| Repurchase of Common Stock | -1,934.80% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -856.96% | -2,886.17% | -1,000.87% | -695.04% | -310.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 176.29% | 76.66% | 30.93% | 43.63% | 67.11% |